Kawwy should make a....

[ponch]

Kawasaki hasn't made any changes since 2009 when the 1700 was introduced. Long in tooth doesn't even describe it.

The revolution is a different engine as is the PA. There are other choices besides Indian. Ducati, BMW and Moto Guzzi make twins that have stonk, handle and stop well too.

I don't see Kawasaki updating the big twins. They probably don't sell many of them and don't see it as a worthwhile investment. HD and Indian seem to be doing ok even considering the entry price and Honda has the GW which does well too. I think Kawasaki missed some opportunities, but it's past and like a lot of folks here, I moved on and I probably will never go back unless they make something compelling, which I doubt.

[BrokeAss]

Originally Posted by ponch

Kawasaki hasn't made any changes since 2009 when the 1700 was introduced. Long in tooth doesn't even describe it.

The revolution is a different engine as is the PA. There are other choices besides Indian. Ducati, BMW and Moto Guzzi make twins that have stonk, handle and stop well too.

I don't see Kawasaki updating the big twins. They probably don't sell many of them and don't see it as a worthwhile investment. HD and Indian seem to be doing ok even considering the entry price and Honda has the GW which does well too. I think Kawasaki missed some opportunities, but it's past and like a lot of folks here, I moved on and I probably will never go back unless they make something compelling, which I doubt.

Why would they invest R&D dollars on a dying segment? The Nomad and Classic were axed because they weren't selling, not because they were obsolete tech. A proper cruiser shouldn't need bluetooth and a TFT screen to be relevant. Honda dropped the VTX line, Suzuki pared down the Boulevard lineup, Harley eliminated a lot of their not-really-a-whole-new-model models...it's a segment wide decrease in sales/interest met with less development and fewer choices. Maybe cruisers will come back some day but for now bikes like the MT-01 are what's selling to a younger buyer not yet genocided by Remdesivir during our recent scamdemic.